Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Advent Life Sciences Fund Iii Lp investment portfolio
Advent Life Sciences Fund Iii Lp has made numerous investments in companies such as Curve Therapeutics, Nerre Therapeutics Holdings, and Cenentry Biosciences within the Healthcare & Life Sciences sector.
vc
Portfolio
5
Team
0
Portfolio (5)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Beacon Therapeutics Holdings Limited Beacon Therapeutics Holdings Limited develops and advances gene‑therapy treatments for retinal diseases that cause blindness, including its lead clinical asset laru‑zova (AGTC‑501) for X‑linked retinitis pigmentosa. The company’s focus is on delivering ophthalmic gene‑therapy products for patients with rare and prevalent retinal disorders. | Healthcare & Life Sciences | London | Confirmed | 2025-08-17 |
| Cenentry Biosciences Limited | Healthcare & Life Sciences | Cambridge | Confirmed | 2026-03-25 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (4)
Advent Life Sciences Fund Iii Lp's positions across portfolio companies2026
- SERIES B2 PREFERRED 0 → 5,143,502
- SERIES B3 PREFERRED 0 → 3,506,934
- ORDINARY 1,083,179 → 0
- SERIES A-1 SEED PREFERRED 1,805,297 → 0
- SERIES A-2 SEED PREFERRED 1,934,804 → 0
- ORDINARY 0.0001 GBP 0 → 1,083,179
- SERIES A-1 SEED PREFERRED 0.0001 GBP 0 → 1,805,297
- SERIES A-2 SEED PREFERRED 0.0001 GBP 0 → 1,934,804
Articles (1)
- Advent Life Sciences Fund III takes 3.1% of Beacon Therapeutics21 Aug 2026Beacon Therapeutics Holdings